Proposed research will investigate the mechanisms underlying behavior/motor deficits consequent to MPTP-induced loss of substantia nigra (SN) dopaminergic neurons and extensive striatal DA depletion and examine the bases for functional recovery following a large DA-depleting lesion. We have previously suggested that volume transmission of DA may play a critical role in functional recovery following a large DA-depleting lesion, and that the regulation of the DA transporter may play a critical role in influencing the ability of DA to diffuse away from its site of release. In the present application, we will use a combination of quantitative and functional techniques (in situ hybridization histochemistry, immunohistochemistry, ligand binding, and in vivo electrochemistry) to study the DA transporter and the presynaptic DA system. We will assess the degree to which functional recovery in MPTP-treated cats is accompanied by regional recovery of and release of DA from residual DA terminals and the degree to which such changes may be accompanied by decreased DA transporter number and/or function. We will also examine potential differences in the above-mentioned measures between animals and spontaneous recovery versus stimulated recovery (with GM1 ganglioside) from parkinsonism. Preliminary data suggests that spontaneous recovery may represent more a true compensatory of adaptive process whereas stimulated recovery may reflect a reactivation of a developmental program and a rebuilding of the natural pattern of DA innervation. Other studies will use quantitative receptor autoradiography, in situ hybridization histochemistry, and in vivo microdialysis to: A) examine postsynaptic dopaminergic mechanisms relating to parkinsonism and functional recovery from parkinsonism and B) examine the contributions of non-dopaminergic systems (GABA, enkephalin, excitatory amino acids) to MPTP-induced parkinsonism and assess the extent to which compensatory changes in these systems may contribute to functional recovery from parkinsonism. Behavioral electrophysiological studies will examine the properties of striatal and motor thalamic neurons in normal, symptomatic, and spontaneous and GM1-recovered MPTP-treated cats performing a learned sensorimotor task. These studies will examine the relationships between restoration of sensorimotor function and the integrity of the pre-synaptic DA system. Parkinson's disease represents a disorder in which compensatory processes have failed. The continued study of MPTP-treated cats is important because they do recover from parkinsonism, and therefore display properties of a successfully compensated system. The proposed research will provide a fuller understanding of the processes underlying functional recovery from extensive DA cell loss.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS023980-09
Application #
2445742
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Oliver, Eugene J
Project Start
1988-07-01
Project End
1997-09-30
Budget Start
1997-07-01
Budget End
1997-09-30
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Allegheny University of Health Sciences
Department
Neurology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19129
Wade, Timothy V; Schneider, Jay S (2004) Striatal preprotachykinin gene expression reflects parkinsonian signs. Neuroreport 15:2481-4
Schroeder, J A; Schneider, J S (2002) GABA-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion. J Neurochem 82:666-73
Schroeder, Joseph A; Schneider, Jay S (2002) GABA(A) and mu-opioid receptor binding in the globus pallidus and endopeduncular nucleus of animals symptomatic for and recovered from experimental Parkinsonism. Brain Res 947:284-9
Rothblat, D S; Schroeder, J A; Schneider, J S (2001) Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism. J Neurosci Res 65:254-66
Schroeder, J A; Schneider, J S (2001) Alterations in expression of messenger RNAs encoding two isoforms of glutamic acid decarboxylase in the globus pallidus and entopeduncular nucleus in animals symptomatic for and recovered from experimental Parkinsonism. Brain Res 888:180-183
Wade, T V; Rothblat, D S; Schneider, J S (2001) Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism. Brain Res 905:111-9
Wade, T; Rothblat, D S; Schneider, J S (2000) Changes in striatal dopamine D(2) receptors in relation to expression of and recovery from experimental parkinsonism. Brain Res 871:281-7
Schroeder, J A; Schneider, J S (2000) Striatal enkephalin gene expression does not reflect parkinsonian signs. Neuroreport 11:1799-802
Rothblat, D S; Schneider, J S (1999) Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study. J Neurochem 72:724-33
Schneider, J S; Schroeder, J A; Rothblat, D S (1998) Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation. Brain Res 813:82-7

Showing the most recent 10 out of 23 publications